The absence of TERT promoter mutations in primary gastric cancer

Gene

Volumn 540, Issue 2, 2014, Pages 266-267

  Liu, Tiantian ^a,b   Liang, Xiuming ^a   Björkholm, Magnus ^b   Jia, Jihui ^a   Xu, Dawei ^b  

^a SHANDONG UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; BLADDER CANCER; CARCINOGENESIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GLIOBLASTOMA; HUMAN; LETTER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; STOMACH CANCER; THYROID CANCER; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TELOMERASE;

EID: 84896542349     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.02.051     Document Type: Letter

References (8)

1. Daniel M., Peek G.W., Tollefsbol T.O. Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012, 498:135-146.
2. Horn S., et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013, 339:959-961.
3. Huang F.W., et al. Highly recurrent TERT promoter mutations in human melanoma. Science 2013, 339:957-959.
4. Killela P.J., et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:6021-6026.
5. Li W., et al. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues. Cancer Letters 2008, 260:28-36.
6. Liu T., et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene 2013, 10.1038/onc.2013.446.
7. Qu Y., et al. Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. International Journal of Cancer 2013, (Nov 28). 10.1002/ijc.28633.
8. Rachakonda P.S., et al. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:17426-17431.